Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an ... The Enzyme-Linked ImmunoSpot (ELISpot) platform assesses cytokine production and is the most commonly ...

Combining multiple vaccines may trigger stronger immune responses in fewer shots, potentially improving the efficacy of ...

Amid a multi-year surge in vaccine misinformation sparked by the Covid-19 pandemic, social media posts claimed that the ...

"He has advised me not to take any mRNA vaccines," she said. She, like many people with long COVID, relies on COVID boosters to avoid reinfections with the virus, which can cause their symptoms to ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Novavax's protein-based technology offers an alternative to mRNA ... vaccine to the market. The stock has been volatile for much of its existence, gaining nearly 2,400% in 2020 when the COVID ...

Concerned that the nation’s health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take ...

HHS Secretary Robert F. Kennedy Jr. is weighing pulling the Covid-19 vaccine from the government’s list of recommended immunizations for children, two people familiar with the discussions told ...

Novavax makes the nation’s only traditional protein-based COVID-19 vaccine. It is still being sold under emergency use authorization — unlike mRNA vaccines made by Pfizer and Moderna that have ...

Next year’s COVID vaccine recommendations from the U.S. Centers for Disease Control and Prevention appear likely to be less expansive than in previous years. Notes from a recent meeting of the ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.